Evidence map›Paper›PMID 41705621›Full record

ArticleAmerican journal of hematology2026

G-CSF for Mobilizing CD34

Akshay Sharma, Allistair Abraham, Monica Bhatia, María Cancio, Sonali Chaudhury, Selim Corbacioglu, Gregory M T Guilcher, Ashish O Gupta, Rabi Hanna, Matthew M Heeney and 8 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Akshay SharmaDepartment of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID https://orcid.org/0000-0003-3281-2081
Allistair AbrahamCenter for Cancer and Immunology Research, Cell Enhancement and Technologies for Immunotherapy, Children's National Hospital, Washington, DC, USA.
Monica BhatiaColumbia University/New York-Presbyterian Morgan Stanley Children's Hospital, New York, New York, USA.
María CancioMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Sonali ChaudhuryDivision of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, Ann & Robert H Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Selim CorbaciogluDepartment of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany.
Gregory M T GuilcherAlberta Children's Hospital, Section of Oncology/Transplant, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Ashish O GuptaDivision of Pediatric Blood and Marrow Transplantation & Cellular Therapy, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.
Rabi HannaDepartment of Pediatric Hematology Oncology and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland, Ohio, USA.
Matthew M HeeneyDivision of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Tami JohnDivision of Hematology, Oncology, and Stem Cell Transplantation, Department of Pediatrics, Stanford University, Palo Alto, California, USA.
Lakshmanan KrishnamurtiDepartment of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
James L LaBelleDivision of the Biological Sciences, The University of Chicago, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0001-6776-4695
Hemalatha G RangarajanDepartment of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Nationwide Children's Hospital, Columbus, Ohio, USA.
Shalini ShenoyDepartment of Pediatrics, Division of Hematology/Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
Elizabeth StengerDepartment of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Crawford StrunkDepartment of Pediatric Hematology Oncology and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland, Ohio, USA.
Courtney D FitzhughCellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0002-5306-7167

Funding

Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell diseaseU01HL163983 · NHLBI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Akshay Sharma, Shengdar Tsai · 2023 to 2026
$4.9M
American Lebanese Syrian Associated CharitiesNHLBI Division of Intramural ResearchNHLBI NIH HHS 1U01HL163983NHLBI NIH HHS U01 HL163983
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

G‐CSFgene therapysickle cell disease

Identifiers

PMID41705621
PMCPMC13139876

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.